How should a pregnant woman in the third trimester with preeclampsia who develops HELLP syndrome be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of HELLP Syndrome in Third Trimester Preeclampsia

Women with HELLP syndrome in the third trimester should be delivered promptly once maternal coagulopathy and severe hypertension are corrected, as delayed delivery carries a 3.4% maternal mortality risk and the syndrome only resolves after delivery. 1

Immediate Stabilization and Monitoring

Upon diagnosis, transfer the patient immediately to a high-dependency unit or intensive care for continuous monitoring. 2 This includes:

  • Continuous blood pressure monitoring with ECG and oxygen saturation 2
  • Central venous pressure monitoring via internal jugular or subclavian catheter, as these patients are typically hypovolemic despite appearing fluid overloaded 3
  • Hourly urinary output monitoring via indwelling catheter (oliguria <400 mL/24h indicates severe disease) 2, 3
  • Serial laboratory monitoring every 6-12 hours: complete blood count, liver enzymes (AST, ALT, LDH), coagulation profile, and renal function 2, 3

Blood Pressure Management

Initiate magnesium sulfate immediately for all women with HELLP syndrome and severe hypertension to prevent eclamptic seizures. 1 This is a Level 1 evidence, strong recommendation. 1

For hypertension control:

  • Non-severe hypertension (140-159/90-109 mmHg): Start oral labetalol, nifedipine, or methyldopa 1
  • Severe hypertension (≥160/110 mmHg): Treat urgently with oral agents first; escalate to IV labetalol or hydralazine if needed 1
  • Target mean arterial pressure: 100-105 mmHg to reduce eclampsia and intracranial hemorrhage risk 3

Correction of Coagulopathy

Platelet transfusion is mandatory when platelets fall below 50,000/mm³ before any surgical intervention, and should be strongly considered at <100,000/mm³ given the increased risk of abnormal coagulation. 1, 2

Additional blood product management:

  • Fresh frozen plasma: Administer 400 mL cautiously (guided by CVP target 3-8 mmHg) to correct coagulopathy 3
  • Packed red blood cells: Transfuse if hemoglobin <10 g/dL 2, 3

Timing and Mode of Delivery

At ≥34 weeks gestation: Deliver immediately after maternal stabilization. 2 This is non-negotiable regardless of laboratory values, as HELLP only resolves after delivery. 2

At <34 weeks gestation: Expectant management may be considered ONLY if all of the following criteria are met: 2

  • Stable maternal condition with no worsening laboratory values
  • No severe symptoms
  • Reassuring fetal status
  • Intensive monitoring capability in a tertiary center

However, deliver immediately at any gestational age if: 2

  • Maternal deterioration (worsening labs, severe symptoms)
  • Fetal compromise (non-reassuring status, abnormal Doppler)
  • Hepatic complications identified on imaging

Mode of delivery: Expect a high cesarean section rate (>70%) due to unfavorable cervix, fetal distress, and maternal deterioration. 2 Vaginal delivery is preferable if cervical conditions are favorable. 4, 5

Antenatal Corticosteroids

For fetal lung maturity (<35 weeks): Give high-dose dexamethasone or betamethasone per national guidance. 1 This is for fetal benefit only.

Critical caveat: Do NOT give corticosteroids to improve maternal HELLP outcomes—they are ineffective for maternal disease. 1, 2 This is a Level 1 evidence, strong recommendation. 1

Hepatic Complication Surveillance

Perform abdominal ultrasound immediately if the patient reports right upper quadrant pain, epigastric pain, or right shoulder pain, as these suggest hepatic hematoma or rupture. 1, 2

Risk is particularly high when platelets <20×10⁹/L. 1 If hepatic failure signs develop, make early referral to a transplant center. 1

Anesthetic Considerations

Regional anesthesia (epidural/spinal) is contraindicated when platelets <100,000/mm³ due to epidural hematoma risk. 2 General anesthesia will be required for cesarean section in these cases. 2

Postpartum Management

Continue intensive monitoring for at least 24-48 hours postpartum, as 30% of HELLP cases occur or worsen after delivery. 2, 4, 5

  • Continue magnesium sulfate for 24 hours post-delivery 1, 3
  • Maintain strict fluid balance to avoid pulmonary edema 1, 3
  • Serial laboratory monitoring every 6-12 hours for 24-48 hours 2
  • Monitor for complications: hepatic hemorrhage, acute renal failure, pulmonary edema 3

The syndrome typically peaks 24 hours after delivery. 3

Critical Pitfalls to Avoid

  • Never delay delivery waiting for laboratory values to normalize—this increases maternal mortality to 3.4% 2
  • Never use regional anesthesia with platelets <100,000/mm³ 2
  • Never give corticosteroids for maternal HELLP improvement 1, 2
  • Never aggressively fluid resuscitate—this significantly increases pulmonary edema risk 3

Future Pregnancy Counseling

Women with prior HELLP syndrome have a 20% recurrence risk. 3 For future pregnancies:

  • First-trimester screening to assess early-onset preeclampsia risk 1
  • Aspirin prophylaxis 150 mg nightly starting before 16 weeks' gestation until 36 weeks or delivery 1, 2
  • Calcium supplementation (1.5-2 g elemental calcium/day) if dietary intake <800 mg/day 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Post-Emergent C-Section for Eclampsia and HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The HELLP syndrome.

Acta clinica Belgica, 2010

Research

The HELLP syndrome: clinical issues and management. A Review.

BMC pregnancy and childbirth, 2009

Related Questions

What is Hemolysis, Elevated Liver enzymes, and Low Platelet count (HELLP) syndrome?
At what stage in pregnancy does HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome occur?
What is the management and treatment of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What is the management of Hellp (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What is the management of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What is the prognosis for a patient with lung adenocarcinoma that has metastasized to the second lumbar vertebra (L2) after the primary lung lesion has resolved following initial therapy?
For an adult with an elevated thyroid‑stimulating hormone (TSH), what does this indicate and how should it be evaluated and managed?
What is the recommended management approach for a skull‑base meningioma, taking into account lesion size, exact location, symptom burden, patient age, and comorbidities?
When should therapeutic‑dose enoxaparin (low‑molecular‑weight heparin) be initiated in a hospitalized adult with a plasma D‑dimer >10 µg/mL and no absolute contraindication to anticoagulation?
A 9‑month‑old infant weighing 10 kg has a persistent, severe cough not improved after a dose of Montair LC Kid (montelukast) 1.5 ml, without fever or cold symptoms; what is the appropriate management?
Can human rabies immune globulin be administered after a patient has received the first dose of rabies vaccine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.